DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2226471/ventas-vtr-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2226471 Feb 14, 2024 - While the top- and bottom-line numbers for Ventas (VTR) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. 0

https://www.zacks.com/stock/news/2225388/is-a-beat-in-the-offing-for-ventas-vtr-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2225388 Feb 13, 2024 - Favorable SHOP operating trends, healthy demand for life-science real estate assets and accretive investments are likely to have benefited Ventas' (VTR) Q4 earnings. 0

https://www.zacks.com/stock/news/2224021/ahead-of-ventas-vtr-q4-earnings-get-ready-with-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2224021 Feb 09, 2024 - Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics. 0

https://www.zacks.com/stock/news/2216074/crown-castle-s-cci-q4-affo-beat-estimate-revenues-down-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2216074 Jan 25, 2024 - Crown Castle's (CCI) Q4 results outshine estimates on better-than-anticipated revenues. However, high interest expense is a concern. It has maintained its 2024 outlook. 0

https://www.zacks.com/stock/news/2203701/here-s-why-investors-should-retain-ventas-vtr-stock-for-now?cid=CS-ZC-FT-analyst_blog|zer_report_update-2203701 Dec 29, 2023 - A rise in healthcare spending by senior citizens and accretive investments in the research portfolio bode well for Ventas (VTR). However, dependence on a few tenants and high interest rates are woes. 0